233 related articles for article (PubMed ID: 34912333)
21. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.
Hong KH; Yoo SA; Kang SS; Choi JJ; Kim WU; Cho CS
Clin Exp Immunol; 2006 Nov; 146(2):362-70. PubMed ID: 17034590
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
23. Expression of platelet-derived growth factor B-chain and platelet-derived growth factor beta-receptor in fibroblasts of scleroderma.
Zheng XY; Zhang JZ; Tu P; Ma SQ
J Dermatol Sci; 1998 Nov; 18(2):90-7. PubMed ID: 9833975
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
[TBL] [Abstract][Full Text] [Related]
25. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
27. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
[TBL] [Abstract][Full Text] [Related]
28. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
29. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts.
Czuwara-Ladykowska J; Gore EA; Shegogue DA; Smith EA; Trojanowska M
Br J Dermatol; 2001 Oct; 145(4):569-75. PubMed ID: 11703282
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
Yokoyama Y; Sekiguchi A; Fujiwara C; Uchiyama A; Uehara A; Ogino S; Torii R; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2018 Oct; 70(10):1661-1672. PubMed ID: 29676521
[TBL] [Abstract][Full Text] [Related]
32. Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis.
Almadori A; Griffin M; Ryan CM; Hunt DF; Hansen E; Kumar R; Abraham DJ; Denton CP; Butler PEM
PLoS One; 2019; 14(7):e0218068. PubMed ID: 31314805
[TBL] [Abstract][Full Text] [Related]
33. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
[TBL] [Abstract][Full Text] [Related]
34. Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1.
Kikuchi K; Kadono T; Ihn H; Sato S; Igarashi A; Nakagawa H; Tamaki K; Takehara K
J Invest Dermatol; 1995 Jul; 105(1):128-32. PubMed ID: 7615966
[TBL] [Abstract][Full Text] [Related]
35. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
36. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
37. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK
Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152
[TBL] [Abstract][Full Text] [Related]
38. Role of PDGF in fibrotic diseases and systemic sclerosis.
Trojanowska M
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v2-4. PubMed ID: 18784131
[TBL] [Abstract][Full Text] [Related]
39. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
